On-Demand

Diabetes CME

Need a refresher on everything related to diabetes? These Diabetes CME courses cover a wide range of topics, from selecting medication to managing comorbidities and complications, as well as the latest advancements in diabetes technology.

CME On-Demand Courses Include

Language – English

Access On Desktop, Tablet & Mobile

2024 package – 5.5 CME Credit Hours (Rx=2.00)
Valid until October 1, 2026

2025 package – 6.5 CME Credit Hours (Rx=1.75)
Valid until August 15, 2027

Diabetes – 2024 Package

Diabetes CME courses take a deep dive into the complications of diabetes and the “Miracle” medications that treat diabetes, giving you the confidence to make better patient care decisions.

CME Courses by Deborah Hinnen, APN, BC-ADM, CDCES, FAAN, FADCES

View Speaker Bio

Watch Speaker Video

The Mirage: Sometimes It’s Not What We Think: T1 V T2 V Lada (Rx=0.25)

This session will help clarify the illusion we sometimes see with the diagnosis of diabetes. While diagnostic criteria is well known, determining T1 v LADA v T2DM are not always clear. Screening and staging for T1D has taken on greater importance now that it may be prevented or delayed. Referral for Tzield treatment is now more important than ever for providers and clinicians. Insulin management for Stage 3 and insulinopenic T2DM will be reviewed.

Staying out of Death Valley: Cardio, Kidney, Metabolic Diseases (Rx=0.25)

Staying out of Death Valley of complications of diabetes is our ultimate goal. Cardo, Kidney metabolic (CKM) diseases are interrelated and must be prevented, screened for and or treated. Data reviewing the medication benefits beyond glucocentric, will be reviewed. Management and referral for micro and macrovascular complications will be discussed.

The Oasis: Miracle Medications (Rx=1.00)

The oasis in the desert is the advent of “Miracle” medications that treat diabetes, slow and/or prevent renal, cardiovascular, OSA, NAFLD and potentially other related areas. A deep dive into these medications, MOA, adverse events, prescribing, titrating will be discussed with case reviews to enhance critical thinking.

Sunscreen Isn’t Enough: Therapeutic Adjustments Through Empowerment, Education and New Technologies (Rx=0.50)

Sunscreen Isn’t Enough will highlight other important strategies to improve outcomes. Patient engagement and empowerment with use of new technology to enhance pattern management and therapeutic adjustments will be reviewed. Continuous glucose sensors, pumps and hypoglycemia treatments are all game changers. People with diabetes (PWD) are driving uptake in these areas.

The Long Tall Drink of Water: Resources to Provide Sustinence

This presentation will share resources found to be successful for clinicians and educators over decades of practice. Patient handouts, web sites, apps and formulary look up tools will help provide sustenance for the busy practitioner.

Diabetes – 2025 Package

You’ll make more confident patient care decisions with this Diabetes CME course. Our experts share the latest on medication, technology, chronic kidney disease, and more.

Amy Butts

CME Courses by Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

View Speaker Bio

Watch Speaker Video

People with diabetes should receive comprehensive care with an interprofessional team. This course discusses taking a person-centered approach to care that involves a relationship between provider and the person with diabetes in treatment management. It reviews the comprehensive medical evaluation and assessment of comorbidities for the individualized person.

Positive health behaviors and psychological well-being are the foundation to improved outcomes for diabetes, prediabetes, and obesity. This course discusses self-management education including nutrition, physical activity, and psychosocial care. Obesity is a chronic and relapsing disease that increases the risk of type 2 diabetes, and the course also reviews weight management and prevention, including pharmacologic and surgical interventions.

There are so many options for medication management with type 2 diabetes, and it’s imperative to take a person-centered approach when selecting it. This course reviews non-insulin medication and initiating and intensifying insulin therapy to meet the needs of the person living with diabetes.

ASCVD is the leading cause of morbidity and mortality for individuals with diabetes, and chronic kidney disease occurs in 20 to 40% of people with diabetes. Complications of diabetes such as retinopathy and neuropathy have profound effects on quality of life. This course focuses on assessing and managing these comorbidities and complications that occur in the people living with diabetes.

Technology has changed our world, including how we manage people living with diabetes. This course discusses multiple technological advancements for diabetes, including CGM and insulin delivery devices. It also examines downloading and interpreting AGP reports to help the provider to implement shared decision making into their practice.

Shopping Cart